MAMTA Health Institute for Mother and Child, B-5, Greater Kailash Enclave-II, New Delhi, India.
Department of Central Research and Innovation, Sumandeep Vidyapeeth Deemed to be University, Vadodara, India.
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4307-4313. doi: 10.31557/APJCP.2022.23.12.4307.
This study aims to estimate the prevalence of human papillomavirus (HPV) vaccine usage and determine the factors for awareness about HPV vaccine among women in reproductive age group.
This is a cross-sectional survey under a cervical cancer prevention study. The sample size was 1020 women, aged 15-49 years [550 in Delhi and 470 in Rohtak]. Bivariate analysis and Fisher exact test along with binary logistic regression analysis were used to determine the factors for awareness.
About 18.0 % [Delhi: 24.2 % and Rohtak: 10.9 %] of the respondents had heard about the vaccine against cervical cancer. The women aged more than 30 years [AOR: 1.35; CI: 0.94, 1.94] were more likely to be aware of cervical cancer vaccine as compare to women of 30 years and less. However, the women from Rohtak [AOR: 0.90; CI: 0.48, 1.66] were less likely to be aware of vaccine against cervical cancer in reference to women aged 30 years and more [AOR: 1.61; CI: 1.01, 2.56] from Delhi. About 0.6 % [Delhi: 1.1 % and Rohtak: 0.0 %] of the respondents had received HPV vaccine.
Women tend to have limited knowledge about cervical cancer vaccine and immunisation practices. The women's demographic makeup varied significantly between the two sites, i.e , Rohtak and Delhi, which had an impact on how well they understood and utilised the cervical cancer vaccination. It is worth mentioning that none of the women from Rohtak had received the immunisation. The awareness of the cervical cancer vaccine among women from the Rohtak was lower than the Delhi women.
本研究旨在估计人乳头瘤病毒(HPV)疫苗的使用情况,并确定生育年龄组妇女对 HPV 疫苗的认识因素。
这是一项在宫颈癌预防研究下进行的横断面调查。样本量为 1020 名年龄在 15-49 岁的女性[德里 550 名,罗塔克 470 名]。采用双变量分析和 Fisher 确切检验以及二元逻辑回归分析来确定意识的因素。
约 18.0%[德里:24.2%和罗塔克:10.9%]的受访者听说过预防宫颈癌的疫苗。年龄大于 30 岁的女性[AOR:1.35;95%CI:0.94,1.94]比 30 岁及以下的女性更有可能了解宫颈癌疫苗。然而,与德里年龄在 30 岁及以上的女性相比,罗塔克的女性[AOR:0.90;95%CI:0.48,1.66]对宫颈癌疫苗的认识较低[AOR:1.61;95%CI:1.01,2.56]。约 0.6%[德里:1.1%和罗塔克:0.0%]的受访者接种了 HPV 疫苗。
妇女对宫颈癌疫苗和免疫接种的认识有限。罗塔克和德里两个地点的妇女人口结构存在显著差异,这影响了她们对宫颈癌疫苗接种的理解和利用程度。值得注意的是,罗塔克没有一名妇女接种了疫苗。罗塔克妇女对宫颈癌疫苗的认识低于德里妇女。